The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Natural products — The future scaffolds for novel antibiotics?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
The role of natural product chemistry in drug discovery
Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381
Self-citationThe influence of natural products upon drug discovery (Antiquity to late 1999)
Newman, D. J., Cragg, G. M., & Snader, K. M. (2000) · Natural Product Reports · doi:10.1039/a902202c · Cited by 1,293
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Self-citationWhere will new antibiotics come from?
Walsh, C. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro727 · Cited by 755
The future challenges facing the development of new antimicrobial drugs
Coates, A., Hu, Y., Bax, R., & Page, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd940 · Cited by 704
Bagley, M. C., Dale, J. W., Merritt, E. A., & Xiong, X. (2005) · Chemical Reviews · doi:10.1021/cr0300441 · Cited by 612
Why is big Pharma getting out of antibacterial drug discovery?
Projan, S. J. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.08.003 · Cited by 503
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Self-citationA genome‐wide strategy for the identification of essential genes in Staphylococcus aureus
Forsyth, R. A., Haselbeck, R. J., Ohlsen, K. L., Yamamoto, R. T., Xu, H., Trawick, J. D., Wall, D., Wang, L., Brown‐Driver, V., Froelich, J. M., et al. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02832.x · Cited by 487
Paetzel, M., Karla, A., Strynadka, N. C. J., & Dalbey, R. E. (2002) · Chemical Reviews · doi:10.1021/cr010166y · Cited by 440
Koller, W. C., Lyons, K., Pahwa, R., & Sf, S. W. (2002) · Cited by 421
A genomics-guided approach for discovering and expressing cryptic metabolic pathways
Zazopoulos, E., Huang, K., Staffa, A., Liu, W., Bachmann, B. O., Nonaka, K., Ahlert, J., Thorson, J. S., Shen, B., & Farnet, C. M. (2003) · Nature Biotechnology · doi:10.1038/nbt784 · Cited by 316
Sneader, W. (2005) · Cited by 302
Actinonin, a Naturally Occurring Antibacterial Agent, Is a Potent Deformylase Inhibitor
Chen, D. Z., Patel, D. V., Hackbarth, C. J., Wang, W., Dreyer, G. B., Young, D. C., Margolis, P. S., Wu, C., Ni, Z.-J., Trias, J., et al. (2000) · Biochemistry · doi:10.1021/bi992245y · Cited by 298
Schlünzen, F., Pyetan, E., Fucini, P., Yonath, A., & Harms, J. M. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04346.x · Cited by 240
Taxonomy, Fermentation, Isolation and Biological Activities.
MORI, H., URANO, Y., ABE, F., FURUKAWA, S., FURUKAWA, S., TSURUMI, Y., SAKAMOTO, K., HASHIMOTO, M., TAKASE, S., HINO, M., et al. (2003) · The Journal of Antibiotics · doi:10.7164/antibiotics.56.72 · Cited by 236
McAlpine, J. B., Bachmann, B. O., Piraee, M., Tremblay, S., Alarco, A.-M., Zazopoulos, E., & Farnet, C. M. (2005) · Journal of Natural Products · doi:10.1021/np0401664 · Cited by 231
Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase Inhibitor
Clements, J. M., Beckett, R. P., Brown, A., Catlin, G., Lobell, M., Palan, S., Thomas, W., Whittaker, M., Wood, S., Salama, S., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.563-570.2001 · Cited by 230
Antibiotics: Where did we go wrong?
Overbye, K. M., & Barrett, J. F. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03285-4 · Cited by 223
Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis
Kimura, K.-I., & Bugg, T. D. H. (2003) · Natural Product Reports · doi:10.1039/b202149h · Cited by 208
Introduction: Antibiotic Resistance
Walsh, & Wright (2005) · Chemical Reviews · doi:10.1021/cr030100y · Cited by 168
Caprazamycin B, a Novel Anti-tuberculosis Antibiotic, from Streptomyces sp.
Igarashi, M., NAKAGAWA, N., Doi, N., Hattori, S., NAGANAWA, H., & HAMADA, M. (2003) · The Journal of Antibiotics · doi:10.7164/antibiotics.56.580 · Cited by 165
On the evolution of functional secondary metabolites (natural products)
Stone, M. J., & Williams, D. H. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb00834.x · Cited by 161
Mannopeptimycins, Novel Antibacterial Glycopeptides from Streptomyces hygroscopicus, LL-AC98
He, H., Williamson, R. T., Shen, B., Graziani, E. I., Yang, H., Sakya, S. M., Petersen, P. J., & Carter, G. T. (2002) · Journal of the American Chemical Society · doi:10.1021/ja020257s · Cited by 150
Antibiotic and chemotherapy : anti-infective agents and their use in therapy
Finch, R. G. (2003) · Cited by 149
Chemistry and Biology of Ramoplanin: A Lipoglycodepsipeptide with Potent Antibiotic Activity
Walker, S., Chen, L., Hu, Y., Rew, Y., Shin, D., & Boger, D. L. (2005) · Chemical Reviews · doi:10.1021/cr030106n · Cited by 139
Margolis, P. S., Hackbarth, C. J., Young, D. C., Wang, W., Chen, D., Yuan, Z., White, R. J., & Trias, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1825-1831.2000 · Cited by 132
PARENTI, F., PAGANI, H., & BERETTA, G. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.247 · Cited by 128
Bacterial Peptide Deformylase Inhibitors: A New Class of Antibacterial Agents
Jain, R., Chen, D., White, R. L., Patel, D., & Yuan, Z. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054367194 · Cited by 127
Taking inventory: antibacterial agents currently at or beyond Phase 1
Bush, K., Macielag, M. J., & Weidner‐Wells, M. A. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.08.013 · Cited by 126
Li, W., Leet, J. E., AX, H. A., GUSTAVSON, D. R., Brown, D. M., TURNER, L., BROWN, K., Clark, J. M., Yang, H., Fung-Tomc, J. C., et al. (2003) · The Journal of Antibiotics · doi:10.7164/antibiotics.56.226 · Cited by 124
New (and not so new) antibacterial targets – from where and when will the novel drugs come?
Projan, S. J. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00197-2 · Cited by 122
In Vitro Activities of OPT-80 and Comparator Drugs against Intestinal Bacteria
Finegold, S. M., Molitoris, D. R., Väisänen, M., Song, Y., Liu, C., & Bolaňos, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4898-4902.2004 · Cited by 122
Stahura, F. L., Godden, J. W., Xue, L., & Bajorath, J. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0003303 · Cited by 118
Paetzel, M., Goodall, J. J., Kania, M., Dalbey, R., & Page, M. G. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401686200 · Cited by 118
Hackbarth, C. J., Chen, D. Z., Lewis, J. G., Clark, K., Mangold, J. B., Cramer, J. A., Margolis, P. S., Wang, W., Koehn, J., Wu, C., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2752-2764.2002 · Cited by 115
In Vitro Activity of OPT-80 against Clostridium difficile
Ackermann, G., Löffler, B., Adler, D., & Rodloff, A. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2280-2282.2004 · Cited by 110
Coronelli, C., White, R. J., Lancini, G., & PARENTI, F. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.253 · Cited by 101
Antimicrobial Evaluation of Nocathiacins, a Thiazole Peptide Class of Antibiotics
Pucci, M. J., Bronson, J. J., Barrett, J. F., DenBleyker, K. L., Discotto, L. F., Fung-Tomc, J. C., & Ueda, Y. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3697-3701.2004 · Cited by 100
Characterization of a Human Peptide Deformylase: Implications for Antibacterial Drug Design
Nguyen, K. T., Hu, X., Colton, C., Chakrabarti, R., Zhu, M. X., & Pei, D. (2003) · Biochemistry · doi:10.1021/bi0346446 · Cited by 99
Theriault, R. J., Karwowski, J. P., JACKSON, M., Girolami, R. L., SUNGA, G. N., VOJTKO, C. M., & COEN, L. J. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.567 · Cited by 99
Credito, K. L., & Appelbaum, P. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4430-4434.2004 · Cited by 97
In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile
Swanson, R. N., Hardy, D. J., Shipkowitz, N. L., Hanson, C. W., Ramer, N. C., FERNANDES, P. B., & Clement, J. J. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1108 · Cited by 92
Somberg, J. C. (2006) · American Journal of Therapeutics · doi:10.1097/00045391-200603000-00020 · Cited by 89
Tiacumicins, a novel complex of 18-membered macrolides. II. Isolation and structure determination.
Hochlowski, J. E., Swanson, S., RANFRANZ, L. M., Whittern, D. N., BUKO, A. M., & McAlpine, J. B. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.575 · Cited by 88
Thomson, C. J., Power, E., Rübsamen‐Waigmann, H., & Labischinski, H. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.08.009 · Cited by 84
Lipiarmycin, a new antibiotic from Actinoplanes. III. Mechanism of action.
SERGIO, S., PIRALI, G., White, R. J., & PARENTI, F. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.543 · Cited by 73
Resistance of Streptococcus pneumoniae to Deformylase Inhibitors Is Due to Mutations in defB
Margolis, P. S., Hackbarth, C. J., López, S., Maniar, M., Wang, W., Yuan, Z., White, R. J., & Trias, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2432-2435.2001 · Cited by 73
Muraymycins, novel peptidoglycan biosynthesis inhibitors: synthesis and SAR of their analogues
Yamashita, A., Norton, E. B., Petersen, P. J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00671-1 · Cited by 69
Ramoplanin: A Lipoglycodepsipeptide Antibiotic
Farver, D., Hedge, D. D., & Lee, S. C. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e397 · Cited by 67
Isolation and structure determination
Howse, P. E., Stevens, I. D. R., & Jones, O. T. (1998) · Springer eBooks · doi:10.1007/978-94-011-5344-7_6 · Cited by 65
Fritsche, T. R., Sader, H. S., Cleeland, R., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1468-1476.2005 · Cited by 62
Appelbaum, P. C., & Jacobs, M. R. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.07.001 · Cited by 59
Can biotech deliver new antibiotics?
Barrett, J. F. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.007 · Cited by 52
New advances in antibiotic development and discovery
Alekshun, M. N. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.2.117 · Cited by 51
Dean, C. R., Narayan, S., Daigle, D. M., Dzink-Fox, J., Puyang, X., Bracken, K. R., Dean, K., Weidmann, B., Yuan, Z., Jain, R., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3129-3135.2005 · Cited by 47
Graul, A. I., & Prous, J. R. (1998) · PubMed · Cited by 37
Regueiro‐Ren, A., Naidu, B. N., Zheng, X., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.061 · Cited by 36
PDF Inhibitors: An Emerging Class of Antibacterial Drugs
Johnson, K., Lofland, D., & Moser, H. E. (2005) · Current Drug Targets - Infectious Disorders · doi:10.2174/1568005053174618 · Cited by 33
Sarubbi, E., Monti, F., Corti, E., et al. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04244.x · Cited by 30
Mannopeptimycins, a novel class of glycopeptide antibiotics active against gram-positive bacteria
He, H. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1884-z · Cited by 30
Hegde, S. G., & Carter, J. (2004) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(04)39025-1 · Cited by 8
(1999) · doi:10.1002/(sici)1521-3773(19990301)38:5<643::aid-anie643>3.0.co;2-g
Cited by
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Self-citationPlatensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
Antibiotics produced by Streptomyces
de Lima Procópio, R. E., da Silva, I. R., Martins, M. K., de Azevedo, J. L., & de Araújo, J. M. (2012) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2012.08.014 · Cited by 735
Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
O’Shea, R., & Moser, H. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700967e · Cited by 689
Novel classes of antibiotics or more of the same?
Coates, A. R., Halls, G., & Hu, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01250.x · Cited by 598
Metadata
- Authors
- Butler, M. S., & Buss, A. D.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 71
- Issue
- 7
- Pages
- 919-929
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W1978970152
- Cited by
- 337
- References
- 66
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.